Arca
Skip to content

Pulpitis

Drug research and approvals for pulpitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 54 studies of pulpitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 54
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 54 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

4 in phase 3, 12 in phase 2, 4 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Ibuprofen
Phase 3 Cyclooxygenase inhibitor
Epinephrine
Phase 3 Adrenergic receptor agonist
Lidocaine
Phase 3 Sodium channel alpha subunit blocker
Articaine
Phase 3 Sodium channel alpha subunit blocker
Ketorolac
Phase 2 Cyclooxygenase inhibitor
Diclofenac
Phase 2 Cyclooxygenase inhibitor
Acetaminophen
Phase 2 Cyclooxygenase inhibitor
Aceclofenac
Phase 2 Cyclooxygenase-2 inhibitor
Bupivacaine
Phase 2 Sodium channel protein type IV alpha subunit blocker
Fentanyl
Phase 2 Mu opioid receptor agonist
Sufentanil
Phase 2 Mu opioid receptor agonist
Bromelains
Phase 2 Unknown
Polihexanide
Phase 2 Cell membrane disrupting agent
Mannitol
Phase 2 Unknown
Poliglusam
Phase 2
Dexamethasone
Phase 1 Glucocorticoid receptor agonist
Zinc oxide
Early phase 1 Sunscreen/skin protectant
Alcohol
Early phase 1
Ferric sulfate
Early phase 1

How Its Trials Ended

288 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 15 whose ending is known, 60% met their primary endpoint, 0% missed it and 40% stopped early.

  • Completed, result not reported13647%
  • Ongoing7225%
  • Status unknown6523%
  • Met its primary endpoint93%
  • Stopped: other or unclear52%
  • Stopped: lack of efficacy10%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.